Novartis, one of the world’s largest pharmaceutical companies, has executed an agreement to sell one of Sandoz Turkey’s manufacturing facilities in Gebze to Generica İlaç, a Turkish company engaged in the manufacturing, marketing and sale of pharmaceutical products since 2007. The transaction includes the transfer of all associated assets and employees of Sandoz Turkey on the Gebze site. The deal is expected to close by mid-2020 subject to obtaining the necessary approvals from regulatory authorities, including the Competition Board, the Gebze Plastic Manufacturers Organized Industrial Zone and the Ministry of Industry and Technology. After closing, Generica İlaç will continue to manufacture and supply certain products to Novartis.
Paksoy is pleased to announce that Elvan Aziz (partner), Nazlı Bezirci (counsel) and Gözde Zorlu (associate) are advising Novartis on this transaction.
Share
Related persons
You can contact us for detailed information.


Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
6 May 2026
Paksoy advised Sapro on Maxis’ EUR 30 million investment to Sapro
Paksoy advised Sapro and its shareholders for the EUR 30 million investment by Maxis Türkiye Green Finance Project VCIF
20 April 2026
Paksoy advises Carrefour on the sale of its stake in CarrefourSA
On 17 April 2026, Carrefour entered into a share purchase agreement to sell its 32.16% stake in CarrefourSA, one of the major supermarket…
10 April 2026
Paksoy advises Anadolu Efes on the acquisition of a majority stake in Mercan Rakı
Anadolu Group has entered into an agreement to acquire a 60% stake in Tariş Üzüm, the producer of Mercan Rakı.
26 March 2026
We are recognised as top-tier by the Legal 500 EMEA 2026
Once again, our firm and lawyers have been recognised as top-tier by the Legal 500 EMEA 2026.
25 March 2026
Paksoy advises Arch Peninsula on its acquisition of Sanipak
Paksoy advises Arch Peninsula on its acquisition of Sanipak, a leading consumer products company, from Eczacıbaşı Holding for USD 600…
18 March 2026
Once again, we are recognised among the top-tier in the Chambers Europe Guide 2026
We are appreciative of the continued top-tier recognition of our firm and lawyers by the Chambers and Partners Europe 2026.